Santé log

AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers

[1] Humbert M, Letard S, Goubard A, et al. Identification of AB8939, a novel synthetic microtubule destabilizer and ALDH inhibitor that overcomes multidrug resistance in tumor cells as a drug ...
Santé log

Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and ...

Dr. Wen-Han Chang, corresponding author, added, “The work highlights why biomarkers cannot be interpreted in isolation. Tumor context—immune composition, metabolic state, and innate ...
Santé log

Face-Art Maestro Dr Jaffer Khan Pioneers Aesthetic Artistry for Advanced Plastic Surgery in Dubai

The Visionary Surgeon Who Uses Face Art Techniques to Sculpt Faces, Ensuring Timeless Harmony and Profound Confidence ...
Santé log

Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances

The global laboratory HbA1c market is estimated to be currently worth over $2 billion annually and is expected to grow to exceed $3.5 billion by 2030. This expected rise in the HbA1c market is ...
Santé log

Booking Health Releases 2026 Rankings of Germany’s Most Trusted Cancer Hospitals for International Patients

Booking Health, a leading platform for international medical travel, announced today the release of its 2026 rankings of Germany’s most trusted cancer hospitals. These certified oncology centers are ...
Santé log

Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline

PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering ...
Santé log

Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

Quipt shareholders to receive US$3.65 per share in cash; Transaction provides immediate liquidity and certainty of value to shareholders; The per share purchase price represents a ...
Santé log

Kraig Biocraft Laboratories Successfully Completes Production Cycle, Delivering Over One Million BAM-1 Alpha Hybrid Eggs for Deployment

"The success of BAM-1 Alpha is reshaping our production capabilities," said Kim Thompson, Founder and CEO of Kraig Labs. "These results reaffirm the power of this hybrid line, and to surpass the ...
Santé log

Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor Functional Beverage Distribution with Three New Direct Store Delivery Partners Across Maine and Pennsylvania

Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced new Direct Store Delivery (DSD) partnerships with Pine State Beverage, ...
Santé log

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins

Under the agreement, Opes will leverage its existing commercial relationships and market experience to identify and engage potential customers primarily in Europe, Israel, and Asia to accelerate ...
Santé log

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Data from FDA-advised study demonstrates Lumee™ Oxygen tissue monitoring is a safe and effective long-term method in PAD patients and will support potential FDA submission; strongly correlates with ...
Santé log

Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration

About Roxadustat Roxadustat, an oral medication, is the first in a new class of medicines comprising HIF-PH inhibitors that promote erythropoiesis, or red blood cell production, through increased ...